Dr Gregory and his team are committed to solving the puzzle that is prostate cancer and saving the lives of so many Australian men.

Scientists working tirelessly in the lab of the Centre for Cancer Biology have identified that high levels of a protein (called quaking) plays a key role in the bad prognosis of prostate cancer tumours that have become resistant to chemotherapy and other treatments.

They have also found this protein is higher in patients with prostate cancer that goes on to spread to other parts of the body, becoming more difficult to treat.

Dr Gregory and the team“We’ve made really good progress in our research since securing funding earlier in 2018,” Dr Gregory explained.

“We screened a very large cohort of prostate cancer patients, in collaboration with colleagues in Canada, finding exactly what we had hoped – that high levels of this protein do indeed correlate with a bad prognosis for prostate cancer and the spread of this disease.

“This now means we can start our work in developing models where we can manipulate this protein and look at its effect on cancer cells in the hope to lead to new treatments for aggressive, hard to treat prostate cancer.”

We look forward to updating you on the next phase of this research in 2019!

support the centre for cancer biology